Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons

scientific article

Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INFDIS/JIU031
P932PMC publication ID4038147
P698PubMed publication ID24436452
P5875ResearchGate publication ID259771492

P50authorDarrick CarterQ30347951
Steven G ReedQ89520964
P2093author name stringAfzal A Siddiqui
Gul Ahmad
Loc Le
Weidong Zhang
Workineh Torben
Raymond T Damian
Gary L White
Roman F Wolf
Souvik Karmakar
David W Carey
Mayeen U Alam
P2860cites workNeglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burdenQ21092296
A research agenda for helminth diseases of humans: The problem of helminthiasesQ21144498
A research agenda for helminth diseases of humans: Intervention for control and eliminationQ21562256
Schistosomiasis vaccinesQ24598949
Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemicQ24635389
Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccineQ24655529
Therapeutic cancer vaccines: past, present, and futureQ26863283
SchistosomiasisQ28215200
Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic reviewQ28477145
Human schistosomiasisQ29619142
Resistance against Schistosoma mansoni induced by immunization of mice with cryopreserved schistosomulaQ67433061
Characterization of Ca(2+)-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoniQ70622173
Characterization of a C3 receptor on the envelope of Schistosoma mansoniQ72651315
Resistance to re-infection after exposure to normal and attenuated schistosome parasites in the baboon modelQ33222727
Trick or treat: the role of vaccines in integrated schistosomiasis controlQ33346303
Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine?Q33372341
Parasites and poverty: the case of schistosomiasisQ33615662
The baboon as a non-human primate model of human schistosome infectionQ33771826
Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicumQ34005663
Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccineQ34071134
Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2.Q34201141
Time to set the agenda for schistosomiasis eliminationQ34266980
The immune response to schistosome antigens in formerly infected travelersQ34422358
Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in UgandaQ34510642
Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya: a cross-sectional studyQ34626132
Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccineQ34721343
Research on calpain of Schistosoma japonicum as a vaccine candidateQ35744769
Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?Q36056272
Trichuris muris: a model of gastrointestinal parasite infectionQ36394382
Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasisQ36882459
Experimental vaccines in animal models for schistosomiasisQ37079841
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate modelQ37216479
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasisQ37315241
Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.Q37413446
Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoniQ37450247
Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stageQ37523953
Th2 immune response against Schistosoma mansoni infectionQ37764539
Therapeutic vaccines against HIV infectionQ38013505
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.Q38013789
Susceptibility or resistance of praziquantel in human schistosomiasis: a reviewQ38050973
Th2 responses in schistosomiasis.Q38058759
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccinesQ38059150
New vaccines for neglected parasitic diseases and dengueQ38098308
Comparison of the FeKal CON-Trate system with the formalin-ethyl acetate technique for detection of intestinal parasitesQ40203860
A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infectionQ40545484
Further development of the baboon as a model for acute schistosomiasisQ40740857
Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasisQ46480693
Molecular cloning and sequence analysis of a calcium-activated neutral protease (calpain) from Schistosoma mansoniQ48198083
CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.Q51972395
SchistosomiasisQ56639209
P433issue12
P407language of work or nameEnglishQ1860
P921main subjecttherapeutic vaccineQ105212712
P304page(s)1929-1940
P577publication date2014-01-16
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleUse of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons
P478volume209